Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers
Research and Reports in Urology · 2022-03 · Volume 14 · 87-108
DOI: 10.2147/rru.s303215 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Research and Reports in Urology, 2022-03. Verfasst von Erin Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
ORCID-Profile: Erin Choi, Pranav Sharma, Werner T W de Riese
Zitieren
APA
Choi, E., Buie, J., Camacho, J., Sharma, P., & de Riese, W. T. W. (2022). Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers. Research and Reports in Urology, Volume 14, 87-108. https://doi.org/10.2147/rru.s303215
Vancouver
Choi E, Buie J, Camacho J, Sharma P, de Riese WTW. Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers. Research and Reports in Urology. 2022;Volume 14:87-108. doi:10.2147/rru.s303215
BibTeX
@article{Choi2022,
author = {Choi, Erin and Buie, John and Camacho, Jaime and Sharma, Pranav and de Riese, Werner T W},
title = {Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers},
journal = {Research and Reports in Urology},
year = {2022},
volume = {Volume 14},
pages = {87--108},
doi = {10.2147/rru.s303215}
}
EUVIMED